These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 15951451)
1. Benefits, harms, and the design of clinical trials. Brand DA Med Decis Making; 2005; 25(3):246-7. PubMed ID: 15951451 [No Abstract] [Full Text] [Related]
2. Are we ready for patient-based effect sizes in clinical-trials research? Lehmann HP Med Decis Making; 2005; 25(3):248-9. PubMed ID: 15951452 [No Abstract] [Full Text] [Related]
9. Clinical trials finance and operations. O'Brien JA J Med Pract Manage; 2007; 22(6):369-71. PubMed ID: 17612316 [TBL] [Abstract][Full Text] [Related]
10. The overall benefits risks and costs of multiple medical interventions may be less favourable than the sum of the benefits risks and costs of those individual interventions. Fitzgerald SP Med Hypotheses; 2007; 69(5):970-3. PubMed ID: 17555886 [TBL] [Abstract][Full Text] [Related]
11. Empirical data and the acceptability of research risk: a commentary on the charitable participation standard. Reynolds WW; Nelson RM Arch Pediatr Adolesc Med; 2008 Jan; 162(1):88-90. PubMed ID: 18180419 [No Abstract] [Full Text] [Related]
12. The problem with optimism in clinical trials. Jansen LA IRB; 2006; 28(4):13-9. PubMed ID: 17036434 [No Abstract] [Full Text] [Related]
13. Curbing industry sponsor's incentive to design post-approval trials that are suboptimal for informing prescribers but more likely than optimal designs to yield favorable results. Falit BP Seton Hall Law Rev; 2007; 37(4):969-1049. PubMed ID: 18363220 [No Abstract] [Full Text] [Related]
14. Who pays for clinical research? Weiss GB Clin Res; 1979 Oct; 27(4):297-9. PubMed ID: 10309043 [No Abstract] [Full Text] [Related]
15. Design and analysis issues for economic analysis alongside clinical trials. Marshall DA; Hux M Med Care; 2009 Jul; 47(7 Suppl 1):S14-20. PubMed ID: 19536012 [TBL] [Abstract][Full Text] [Related]
16. A primer on the design, conduct, and interpretation of clinical trials. Appel LJ Clin J Am Soc Nephrol; 2006 Nov; 1(6):1360-7. PubMed ID: 17699370 [TBL] [Abstract][Full Text] [Related]
17. Informing the selection of futility stopping thresholds: case study from a late-phase clinical trial. Hughes S; Cuffe RL; Lieftucht A; Garrett Nichols W Pharm Stat; 2009; 8(1):25-37. PubMed ID: 18383194 [TBL] [Abstract][Full Text] [Related]
18. Legal and ethical issues associated with patient recruitment in clinical trials: the case of competitive enrolment. Caulfield T Health Law Rev; 2005; 13(2-3):58-61. PubMed ID: 16459415 [No Abstract] [Full Text] [Related]
19. Patient care cancer clinical trials at the National Cancer Institute: a resource for payers and providers. Pearson D Manag Care Q; 2002; 10(1):33-7. PubMed ID: 15988953 [TBL] [Abstract][Full Text] [Related]
20. Research versus innovation: real differences. Morreim H Am J Bioeth; 2005; 5(1):42-3; author reply W15-8. PubMed ID: 16036658 [No Abstract] [Full Text] [Related] [Next] [New Search]